U3P1287/01

· U3 Pharma GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for U3P1287/01, covering 2010-07-29 to 2010-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors [Phase 1]